Cell and gene therapies for degenerative eye diseases are still a long way off, but they have the potential to make a transformative difference to people’s lives. Vision impairment and loss ...

Shihabeddin et al utilized single-cell RNA-Seq analysis of adult P23H zebrafish animals to identify transcription factors (e2fs, Prdm1a, Sp1) expressed selectively in neural progenitors and immature ...

A new stem cell therapy has repaired blinding damage to the cornea in 93% of patients in an early clinical trial. The cornea ...

Ula Jurkunas, an ophthalmologist and associate director of the cornea service at Mass Eye and Ear who performed Kharufeh's surgery. "This is the first stem cell trial in the cornea in the U.S ...

Aurion Biotech has launched its cell therapy Vyznova for serious eye disorder bullous keratopathy in Japan, its debut market, becoming an alternative to corneal replacement using donor tissue.

Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia type 2 (MacTel), a rare eye disease leading to progressive and ...